Stock-Based Compensation (Tables)

9 Months Ended

Oct. 29, 2016

Stock-based compensation expense by type of grant for each period presented was as follows (in thousands):



	Three Months Ended						Nine Months Ended
	October 29, 2016			October 31, 2015			October 29, 2016			October 31, 2015
Stock appreciation rights (“SARs”)	$	—		$	—		$	—		$	30
Non-vested stock	1,362			1,719			5,311			5,133
Performance shares	(569		)	1,278			2,034			3,763
Total compensation expense	793			2,997			7,345			8,926
Related tax benefit	(298		)	(1,126		)	(2,762		)	(3,356		)
Stock-based compensation expense, net of tax	$	495		$	1,871		$	4,583		$	5,570

The following table summarizes SARs activity for the nine months ended October 29, 2016:



SARs	Number of Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (years)	Aggregate Intrinsic Value (in thousands)
Outstanding, vested and exercisable at January 30, 2016	224,400		$	17.16
Forfeited	(39,750	)	14.66
Outstanding, vested and exercisable at October 29, 2016	184,650		$	17.70	1.1	$	—

The following table summarizes non-vested stock activity for the nine months ended October 29, 2016:



Non-vested Stock	Number of Shares		Weighted Average Grant Date Fair Value
Outstanding at January 30, 2016	894,526		$	20.20
Granted	1,396,947		6.78
Vested	(371,656	)	19.45
Forfeited	(238,290	)	12.25
Outstanding at October 29, 2016	1,681,527		10.34

The following table summarizes information about the performance shares that were outstanding at October 29, 2016:



Period Granted	Target Shares Outstanding at January 30, 2016	Target Shares Granted	Target Shares Vested		Target Shares Forfeited		Target Shares Outstanding at October 29, 2016	Weighted Average Grant Date Fair Value Per Share
2014	160,423	—	(3,438	)	(36,667	)	120,318	$	33.84
2015	223,876	—	(6,983	)	(45,707	)	171,186	28.33
2016	—	451,680	(5,168	)	(90,439	)	356,073	8.69
Total	384,299	451,680	(15,589	)	(172,813	)	647,577